Journal article
TIPS to decide whether to prescribe aspirin for the primary prevention of cardiovascular events in chronic kidney disease
Abstract
Aspirin effectively prevents subsequent cardiovascular events. A post hoc subgroup analysis of the International Polycap Study 3 (TIPS-3) trial suggests that patients with chronic kidney disease might also benefit from aspirin for primary prevention. We consider the merits of doing so in practice.
Authors
Roshanov PS; Garg AX
Journal
Kidney International, Vol. 103, No. 2, pp. 261–263
Publisher
Elsevier
Publication Date
February 2023
DOI
10.1016/j.kint.2022.10.018
ISSN
0085-2538